These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25019625)

  • 1. Current status of cancer care for young patients with nasopharyngeal carcinoma in Jakarta, Indonesia.
    Adham M; Stoker SD; Wildeman MA; Rachmadi L; Gondhowiardjo S; Atmakusumah D; Gatot D; Fles R; Greijer AE; Hermani B; Middeldorp JM; Tan IB
    PLoS One; 2014; 9(7):e102353. PubMed ID: 25019625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia.
    Wildeman MA; Fles R; Herdini C; Indrasari RS; Vincent AD; Tjokronagoro M; Stoker S; Kurnianda J; Karakullukcu B; Taroeno-Hariadi KW; Hamming-Vrieze O; Middeldorp JM; Hariwiyanto B; Haryana SM; Tan IB
    PLoS One; 2013; 8(5):e63706. PubMed ID: 23675501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, Indonesia.
    Wildeman MA; Fles R; Adham M; Mayangsari ID; Luirink I; Sandberg M; Vincent AD; Fardizza F; Musa Z; Armiyanto ; Middeldorp JM; Gerritsen G; Suwanto R; Tan IB
    PLoS One; 2012; 7(3):e32756. PubMed ID: 22431981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
    Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
    Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
    Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
    Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study.
    Xu Y; Chen X; Zhang M; Xiao Y; Zong J; Guo Q; Qiu S; Zheng W; Lin S; Pan J
    Cancer Med; 2017 Oct; 6(10):2213-2221. PubMed ID: 28879654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study: current problems in radiotherapy for nasopharyngeal carcinoma in yogyakarta, indonesia.
    Stoker SD; Wildeman MA; Fles R; Indrasari SR; Herdini C; Wildeman PL; van Diessen JN; Tjokronagoro M; Tan IB
    PLoS One; 2014; 9(1):e85959. PubMed ID: 24465811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases.
    Yan Z; Xia L; Huang Y; Chen P; Jiang L; Zhang B
    Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1454-60. PubMed ID: 23830224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004-2008.
    Chee Ee Phua V; Loo WH; Yusof MM; Wan Ishak WZ; Tho LM; Ung NM
    Asian Pac J Cancer Prev; 2013; 14(8):4567-70. PubMed ID: 24083703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
    BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal carcinoma in children and adolescents - a single institution experience of 158 patients.
    Liu W; Tang Y; Gao L; Huang X; Luo J; Zhang S; Wang K; Qu Y; Xiao J; Xu G; Yi J
    Radiat Oncol; 2014 Dec; 9():274. PubMed ID: 25477058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Five-Year Survival Rate of Patients with Nasopharyngeal Carcinoma Based on Tumor Response after Receiving Neoadjuvant Chemotherapy, Followed by Chemoradiation, in Indonesia: A Retrospective Study.
    Dwijayanti F; Prabawa A; Besral ; Herawati C
    Oncology; 2020; 98(3):154-160. PubMed ID: 31995803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
    Siti-Azrin AH; Norsa'adah B; Naing NN
    BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.
    Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Guo L; Mo HY; Zhao C; Guo X; Chen MY; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    BMC Cancer; 2016 Oct; 16(1):774. PubMed ID: 27717335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.
    Zeng L; Tian YM; Sun XM; Huang Y; Chen CY; Han F; Liu S; Lan M; Guan Y; Deng XW; Lu TX
    Strahlenther Onkol; 2014 Oct; 190(11):993-1000. PubMed ID: 24838409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential factors associated with clinical stage of nasopharyngeal carcinoma at diagnosis: a case-control study.
    Ren JT; Li MY; Wang XW; Xue WQ; Ren ZF; Jia WH
    Chin J Cancer; 2017 Sep; 36(1):71. PubMed ID: 28870229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
    Li Y; Chen QY; Tang LQ; Liu LT; Guo SS; Guo L; Mo HY; Chen MY; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Shao JY; Sun Y; Tan J; Chen S; Ma J; Zhao C; Mai HQ
    BMC Cancer; 2017 Aug; 17(1):567. PubMed ID: 28836950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
    Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.
    Tao CJ; Liu X; Tang LL; Mao YP; Chen L; Li WF; Yu XL; Liu LZ; Zhang R; Lin AH; Ma J; Sun Y
    Chin J Cancer; 2013 Oct; 32(10):525-32. PubMed ID: 24016394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.